Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 17, 2017 - Issue 3
Submit an article Journal homepage
873
Views
10
CrossRef citations to date
0
Altmetric
Review

Top-down approach to biological therapy of Crohn’s disease

Simon HirschmannMedical Clinic 1, Department of Medicine, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, GermanyView further author information
&
Markus F. NeurathMedical Clinic 1, Department of Medicine, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, GermanyCorrespondence[email protected]
View further author information
Pages 285-293 | Received 03 Oct 2016, Accepted 23 Jan 2017, Published online: 06 Feb 2017

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Timna Naftali. (2020) An overview of cannabis based treatment in Crohn’s disease. Expert Review of Gastroenterology & Hepatology 14:4, pages 253-257.
Read now
Laurent Peyrin-Biroulet, Silvio Danese, Fraser Cummings, Raja Atreya, Kay Greveson, Burkhard Pieper & Taegyun Kang. (2019) Anti-TNF biosimilars in Crohn’s Disease: a patient-centric interdisciplinary approach. Expert Review of Gastroenterology & Hepatology 13:8, pages 731-738.
Read now

Articles from other publishers (8)

Rosario Medina-Medina, Eva Iglesias-Flores, Jose M. Benítez, Sandra Marín-Pedrosa, Isabel Salgueiro-Rodríguez, Clara I. Linares, Sandra González-Rubio, Pilar Soto-Escribano, Beatriz Gros, Manuel L. Rodríguez-Perálvarez, José L. Cabriada, María Chaparro, Javier P. Gisbert, Eduardo Chicano-Gálvez, Ignacio Ortea, Gustavo Ferrín, Valle García-Sánchez & Patricia Aguilar-Melero. (2023) Development of a Prediction Model for Short-Term Remission of Patients with Crohn’s Disease Treated with Anti-TNF Drugs. International Journal of Molecular Sciences 24:10, pages 8695.
Crossref
Su Hyun Park & Sang Hyoung Park. (2022) Personalized medicine in inflammatory bowel disease: Perspectives on Asia. Journal of Gastroenterology and Hepatology 37:8, pages 1434-1445.
Crossref
Peter L Lakatos, Gilaad G Kaplan, Brian Bressler, Reena Khanna, Laura Targownik, Jennifer Jones, Yasmine Rahal, Kevin McHugh & Remo Panaccione. (2022) Cost-Effectiveness of Tight Control for Crohn’s Disease With Adalimumab-Based Treatment: Economic Evaluation of the CALM Trial From a Canadian Perspective. Journal of the Canadian Association of Gastroenterology 5:4, pages 169-176.
Crossref
Steven J Edwards, Samantha Barton, Mariana Bacelar, Charlotta Karner, Peter Cain, Victoria Wakefield & Gemma Marceniuk. (2021) Prognostic tools for identification of high risk in people with Crohn’s disease: systematic review and cost-effectiveness study. Health Technology Assessment 25:23, pages 1-138.
Crossref
Ryan C Ungaro, Saurabh Aggarwal, Ozlem Topaloglu, Wan-Ju Lee, Ryan Clark & Jean-Frederic Colombel. (2020) Systematic review and meta-analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease. Alimentary Pharmacology & Therapeutics 51:9, pages 831-842.
Crossref
M Ellen Kuenzig, Eric I Benchimol, Lawrence Lee, Laura E Targownik, Harminder Singh, Gilaad G Kaplan, Charles N Bernstein, Alain Bitton, Geoffrey C Nguyen, Kate Lee, Jane Cooke-Lauder & Sanjay K Murthy. (2019) The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization. Journal of the Canadian Association of Gastroenterology 2:Supplement_1, pages S17-S33.
Crossref
Cristiano Pagnini, Spyros I. Siakavellas & Giorgos Bamias. (2018) Systematic Review with Network Meta-Analysis: Efficacy of Induction Therapy with a Second Biological Agent in Anti-TNF-Experienced Crohn’s Disease Patients. Gastroenterology Research and Practice 2018, pages 1-9.
Crossref
Marcel Vetter & Markus F. Neurath. (2018) Treatment Perspectives in Crohn’s Disease. Digestion 98:3, pages 135-142.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.